Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.
about
Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenograftsMultiparametric MRI biomarkers for measuring vascular disrupting effect on cancerKML001 displays vascular disrupting properties and irinotecan combined antitumor activities in a murine tumor model.Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.Arsenic Trioxide as a Vascular Disrupting Agent: Synergistic Effect with Irinotecan on Tumor Growth Delay in a CT26 Allograft Model.Evaluation of Nonradiative Clinical Imaging Techniques for the Longitudinal Assessment of Tumour Growth in Murine CT26 Colon Carcinoma.Vascular disruption in combination with mTOR inhibition in renal cell carcinoma.Acute vascular disruption by 5,6-dimethylxanthenone-4-acetic Acid in an orthotopic model of human head and neck cancer.Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer.Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis.
P2860
Q30452632-2C64D8D0-08D8-4934-8A07-DC7936CD60DBQ33820595-D0E985C4-5DD3-487A-B06F-22EC9432A96BQ33989239-DAB75999-FF31-4C46-B224-1108C04DBB9AQ34303312-912FF012-EE42-4EBF-8271-674F243A9F91Q34538659-AD28B159-8A49-46B6-98E0-915A4C44A7A4Q34551903-D1EA5B75-48E3-4DF0-A05A-DFAF1D9176CEQ35623101-20E2E733-17B8-486D-932E-91ECE6896EC6Q36613318-EA7C581D-8C90-486E-926B-E696AE2ADBE5Q37019989-AFD6E1DB-25D7-4F0C-8665-107F3E84C535Q37154148-5CED0B3D-2619-4B23-9C97-95B4094C7A91Q37313683-B7178E91-9A83-46A4-AF98-E082A0D7D4B9Q37694429-D8A0D23C-19CE-4C2E-B5F2-4621FCCF5F16Q38168371-293ED5CF-BA3F-496E-8E93-454377618786Q38772275-A7E87C7B-4AD2-46BE-AA2F-D4717F1E771C
P2860
Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Assessment of the early effect ...... opic versus orthotopic tumors.
@en
type
label
Assessment of the early effect ...... opic versus orthotopic tumors.
@en
prefLabel
Assessment of the early effect ...... opic versus orthotopic tumors.
@en
P2093
P2860
P1476
Assessment of the early effect ...... opic versus orthotopic tumors.
@en
P2093
David A Bellnier
Mukund Seshadri
Richard T Cheney
P2860
P304
P356
10.1016/J.IJROBP.2008.07.043
P407
P577
2008-11-01T00:00:00Z